// App-Quantinova.ai

PO1989 : Noncanonical PAR-1 Signalling Leads to Profibrotic Effects in Podocytes in Response to Steroid-Resistant Nephrotic Syndrome Disease Plasma

Researchers

Presenter

  • Chesor Musleeha

Principal Investigators

  • Tuffin JackP

  • May CarlJ

  • Welsh GavinIain

  • Saleem Moin

Medical Centers

  • University of Bristol, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Urology

Disease

  • Steroid-resistant nephrotic syndrome

Biomarkers

  • N/A

Drug/Treatment

  • RWJ-56110

  • Vorapaxar

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved